2m 2m 2m 2m 2m 2m 2m
Skye Bioscience (SKYE)
NASDAQ
$1.95-$0.09 (-4.41%)
Price as of Sep 11, 2026 7:31 PM EDT- $9.0MMarket Cap
- -94.00%1-Year Change
- BiotechnologyIndustry
Skye Bioscience (SKYE)
$1.95-$0.09 (-4.41%)
SKYE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.04 | ||
Change | -$0.04 (-1.92%) | ||
Open | $2.08 | ||
High | $2.09 | ||
Low | $1.99 | ||
Previous Close | $2.08 | ||
Volume | 66,179 | ||
30-Day Average Volume | 184,926 | ||
1-Week Change | 9.68% | ||
1-Month Change | -52.86% | ||
1-Year Change | -94.00% | ||
3-Year Change | -99.98% | ||
5-Year Change | -99.98% | ||
Fundamentals | |||
Shares Outstanding | 4.4M | ||
Total Assets | $11.0M | ||
Market Cap | $9.0M | ||
Enterprise Value | $1.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.8M | ||
Free Cash Flow | -$7.1M | ||
EBIT | -$10.8M | ||
EBITDA | -$10.6M | ||
Net Working Capital | -$572,215.00 | ||
EPS | -$2.16 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -18 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 08/24/2026 | ||
Earnings & Revenue